Collagen Solutions (COS)

 

COS Share PerformanceMore

52 week high6.4780 30/12/16
52 week low2.6000 12/12/17
52 week change -3.2500 (-53.06%)
4 week volume11,524,275 19/11/17

Media for (COS)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Collagen Solutions appoints CFO

Collagen Solutions has appointed Hilary Spence as chief financial officer and a director from 3 Jan. She will take over from...

Appointment of Chief Financial Officer

RNS Number: 2585Z Collagen Solutions PLC 14 December 2017 Collagen Solutions Plc (the "Company" or the "Group") Appointment of Chief Financial Officer Collagen Solutions plc (AIM: COS), a global supplier, developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine applications including orthopaedics, dental...

Collagen Solutions H1 losses widen

Collagen Solutions' revenue and other income remained flat in the six months to the end of September at 1.86m (H1 2016: 1.8...

Half-year Report

RNS Number: 3357Y Collagen Solutions PLC 05 December 2017 Collagen Solutions Plc (the "Company" or the "Group") Half Yearly Report Interim Results for the six months ended 30 September 2017 Collagen Solutions plc (AIM: COS), a global supplier, developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine ap...

Second Price Monitoring Extn

RNS Number: 6431X Collagen Solutions PLC 27 November 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determi...

Price Monitoring Extension

RNS Number: 6421X Collagen Solutions PLC 27 November 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the exe...

Collagen Solutions first half revenues slip

Collagen Solutions expects first half revenue and other income to be slightly lower than last time at 1.86m, (H1 2016: 1.89m). I...

Trading update and notice of results

RNS Number: 6453U Collagen Solutions PLC 26 October 2017 Collagen Solutions Plc (the "Company" or the "Group") Trading Update and Notice of Results Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen-based biomaterials for use in research, diagnostics, medical devices, and regenerative medicine, provides an update on...

Fundamental DataMore

EPS-0.95
Dividend yield0 %

Latest discussion posts More

  • Video: COS presentation at Hardman

    Investor presentation by Collagen Solutions CEO Jamal Rushdy at the Hardman & Co?s Investors Forum 20th September ...
    28-Sep-2017
    piw
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS PLC (COS), out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions has ...
    3-May-2016
    FoxRed
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS, out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions announced yesterday ...
    27-Apr-2016
    FoxRed

Users' HoldingsMore

Users who hold Collagen Solutions also hold..

Codes & Symbols

ISINGB00B94T6Y14
SymbolsCOS, LSE:COS, COS.L, COS:LN, LON:COS, XLON:COS

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account